Adcetris 50 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBQ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $104,085
Award facts
- Contract value 100% obligated
- $104,085.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $104,085.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. The award, issued on December 5, 2025, with an ultimate completion date of December 29, 2025, carries no set-aside designation, indicating the contractor competed in unrestricted procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply chains for Department of Defense healthcare facilities worldwide.
As a regional prime vendor contractor under the PPV-G GEN V program, DMS Pharmaceutical Group has demonstrated consistent performance in delivering a comprehensive portfolio of pharmaceuticals, biologics, and medical consumables to support military medical operations globally. The contractor's single-award IDC, valued at $499,999,999 through December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for diverse pharmaceutical requirements. Adcetris, an oncology therapeutic agent, represents a specialized product within the contractor's broader pharmaceutical distribution capabilities, reflecting the company's role as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBQ0?
SPE2DR26FFBQ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FFBQ0 worth?
The government has obligated $104,085 on SPE2DR26FFBQ0.
Is contract SPE2DR26FFBQ0 an order under another contract?
Yes. SPE2DR26FFBQ0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBQ0 competed?
The extent of competition for SPE2DR26FFBQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award